• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

2
1
1
1
1

COUNTRY

1

CATEGORIES

  • 12
  • 7
  • 6
  • 6
  • 3
  • 2
  • 1
  • 1
  • 1

PRICE

0
0
2
38

PUBLISHED

0
3
21
38

PRODUCT TYPE

38

Search "Biotest AG-Therapeutic Competitors Report" returned 38 results.

PRODUCT TITLE

Critical Care Market to 2019 - Growth from Factor Concentrates New Indications and Increasing Demand for Albumin in Asia-Pacific

GBI Research, the leading business intelligence provider, has released its latest research, “Critical Care Market to 2019 - Growth from Factor Concentrates New Indications and Increasing Demand for...

May 2013
FROM

Monoclonal Antibodies Market in Rheumatoid Arthritis to 2018 - Market Characterized by Large and Diversified Pipeline and Low Threat of Biosimilar Sales Erosion

The currently marketed monoclonal antibodies are clinically and commercially highly successful products in the rheumatoid arthritis market, constituting four of the global top 20 best-selling drugs...

January 2013
FROM

Critical Care Market to 2017 - Shift of Focus towards PCC, Factor Concentrates and Antithrombins due to Better Safety and Efficacy Profiles

GBI Research's report, “Critical Care Market to 2017 - Shift of Focus towards PCC, Factor Concentrates and Antithrombins due to Better Safety and Efficacy Profiles” provides in-depth analysis of drivers...

September 2011
FROM

Fibrinogen Deficiency (Factor I Deficiency) - Pipeline Review, H2 2014

Fibrinogen Deficiency (Factor I Deficiency) - Pipeline Review, H2 2014 Summary This, ‘Fibrinogen Deficiency (Factor I Deficiency) - Pipeline Review, H2 2014’, provides an overview of the Fibrinogen...

September 2014
FROM
Blood Banking And Blood Products - Global Strategic Business Report Blood Banking And Blood Products - Global Strategic Business Report - Product Thumbnail Image

Blood Banking And Blood Products - Global Strategic Business Report

This report analyzes the worldwide markets for Blood Banking and Blood Products in US$ Million by the following Product Segments: Blood Components and Plasma Products (Whole Blood & Cellular Components,...

October 2012
FROM

Critical Healthcare Market to 2017 - Shift of Focus towards PCC, Factor Concentrates and Antithrombins due to Better Safety and Efficacy Profiles

“Critical Healthcare Market to 2017 - Shift of Focus towards PCC, Factor Concentrates and Antithrombins due to Better Safety and Efficacy Profiles” The report provides in-depth analysis of drivers and...

September 2011
FROM

Community Acquired Pneumonia - Pipeline Review, H2 2014

Community Acquired Pneumonia - Pipeline Review, H2 2014 Summary This, ‘Community Acquired Pneumonia - Pipeline Review, H2 2014’, provides an overview of the Community Acquired Pneumonia’s therapeutic...

November 2014
FROM

Chronic Plaque Psoriasis - Pipeline Review, H1 2015

Chronic Plaque Psoriasis - Pipeline Review, H1 2015 Summary This, ‘Chronic Plaque Psoriasis - Pipeline Review, H1 2015’, provides an overview of the Chronic Plaque Psoriasis’s therapeutic pipeline. This...

January 2015
FROM

Chronic Plaque Psoriasis - Pipeline Review, H2 2014

Chronic Plaque Psoriasis - Pipeline Review, H2 2014 Summary This, ‘Chronic Plaque Psoriasis - Pipeline Review, H2 2014’, provides an overview of the Chronic Plaque Psoriasis’s therapeutic pipeline. This...

October 2014
FROM

Chronic Plaque Psoriasis - Pipeline Review, H1 2014

Chronic Plaque Psoriasis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Chronic Plaque Psoriasis - Pipeline Review, H1 2014’, provides an overview of the Chronic Plaque Psoriasis’s therapeutic...

April 2014
FROM

Bladder Cancer - Pipeline Review, H2 2014

Bladder Cancer - Pipeline Review, H2 2014 Summary This, ‘Bladder Cancer - Pipeline Review, H2 2014’, provides an overview of the Bladder Cancer’s therapeutic pipeline. This report provides comprehensive...

July 2014
FROM

Relapsed Multiple Myeloma - Pipeline Review, H1 2015

Relapsed Multiple Myeloma - Pipeline Review, H1 2015 Summary: This, ‘Relapsed Multiple Myeloma - Pipeline Review, H1 2015’, provides an overview of the Relapsed Multiple Myeloma’s therapeutic...

March 2015
FROM

Relapsed Multiple Myeloma - Pipeline Review, H2 2014

Relapsed Multiple Myeloma - Pipeline Review, H2 2014 Summary This, ‘Relapsed Multiple Myeloma - Pipeline Review, H2 2014’, provides an overview of the Relapsed Multiple Myeloma’s therapeutic pipeline. This...

September 2014
FROM

Refractory Multiple Myeloma - Pipeline Review, H1 2015

Refractory Multiple Myeloma - Pipeline Review, H1 2015 Summary This, ‘Refractory Multiple Myeloma - Pipeline Review, H1 2015’, provides an overview of the Refractory Multiple Myeloma’s therapeutic...

January 2015
FROM

Community Acquired Pneumonia - Pipeline Review, H1 2014

Community Acquired Pneumonia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Community Acquired Pneumonia - Pipeline Review, H1 2014’, provides an overview of the Community Acquired Pneumonia’s...

May 2014
FROM

Fibrinogen Deficiency (Factor I Deficiency) - Pipeline Review, H1 2015

Fibrinogen Deficiency (Factor I Deficiency) - Pipeline Review, H1 2015 Summary This, ‘Fibrinogen Deficiency (Factor I Deficiency) - Pipeline Review, H1 2015’, provides an overview of the Fibrinogen...

March 2015
FROM

Bladder Cancer - Pipeline Review, H1 2014

Bladder Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Bladder Cancer - Pipeline Review, H1 2014’, provides an overview of the Bladder Cancer’s therapeutic pipeline. This report...

February 2014
FROM

Community Acquired Pneumonia - Pipeline Review, H1 2015

Community Acquired Pneumonia - Pipeline Review, H1 2015 Summary This, ‘Community Acquired Pneumonia - Pipeline Review, H1 2015’, provides an overview of the Community Acquired Pneumonia’s therapeutic...

January 2015
FROM

Systemic Lupus Erythematosus - Pipeline Review, H1 2014

Systemic Lupus Erythematosus - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Systemic Lupus Erythematosus - Pipeline Review, H1 2014’, provides an overview of the Systemic Lupus Erythematosus’s...

February 2014
FROM

Systemic Lupus Erythematosus - Pipeline Review, H2 2014

Systemic Lupus Erythematosus - Pipeline Review, H2 2014 Summary This, ‘Systemic Lupus Erythematosus - Pipeline Review, H2 2014’, provides an overview of the Systemic Lupus Erythematosus’s therapeutic...

July 2014
FROM
Loading Indicator

Our Clients

Hexcel Corporation Harrods Ltd. Bayer AG Google, Inc. Boeing Company Harley Davidson Motor Company SwissCom AG